Insight into Bortezomib Focusing on Its Efficacy against P-gp-Positive MDR Leukemia Cells.

Int J Mol Sci · 2021 · PMC8197160 · PMID 34071136

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

weakly significantno p-value reported

Because there were weakly significant differences between the IC 50 values of the S cells and the R or T cells, it can be concluded that BOR affects S, R, and T cells with approximately equal efficacy.

also in 1,387 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.